BSD Medical to Present at The 16th Annual Rodman & Renshaw Global Investment Conference on September 10, 2014
August 27 2014 - 9:15AM
Business Wire
BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD)
(www.BSDMedical.com), a leading provider of medical systems that
treat cancer and benign diseases using heat therapy, today
announced it will be featured as a presenting company at the 16th
Annual Rodman & Renshaw Global Investment Conference, sponsored
by H.C. Wainwright & Co., LLC. The investor conference is being
held September 8-10, 2014 at The Palace Hotel in New York City.
William Barth, BSD Medical’s Chief Financial Officer, will
provide an overview of BSD’s business during a live presentation on
Wednesday, September 10 at 1:15pm. Mr. Barth will also be available
to participate in one-on-one meetings with institutional investors
who are registered to attend the conference. Interested investors
should contact the conference organizers, or BSD Medical investor
relations at tross@finprofiles.com.
Event: 16th Annual Rodman & Renshaw Global Investment
ConferenceWhen: September 10, 2014Time: 1:15 p.m. (Eastern
Time)Location: Kennedy II Salon (4th Floor); The Palace Hotel in
New York City
A copy of BSD Medical’s powerpoint presentation will be
available for the public to access via the Investor Relations
section of the Company’s corporate website.
About BSD Medical Corporation
BSD Medical Corporation develops, manufactures, markets and
services systems to treat cancer and benign diseases using heat
therapy delivered using focused microwave energy and radiofrequency
(RF). BSD’s product lines include ablation and hyperthermia
treatment systems. BSD’s microwave ablation system has been
developed as a stand-alone therapy to ablate and destroy soft
tissue. The Company has developed extensive intellectual property,
multiple products in the market, and well established distribution
in the United States, Europe and Asia. BSD’s hyperthermia cancer
treatment systems, which have been in use for several years in the
United States, Europe and Asia, are used to treat certain tumors
with heat (hyperthermia) while increasing the effectiveness of
other therapies such as radiation therapy. Certain of the Company’s
products have received regulatory approvals in the United States,
Europe and China. For further information visit BSD Medical's
website at www.BSDMedical.com.
For BSD Medical CorporationTricia Ross,
310-622-8226investor@bsdmc.com